Erratum to: Starting Insulin in Type 2 Diabetes: Real-World Outcomes After the First 12 Months of Insulin Therapy in a New Zealand Cohort

被引：0
|
作者：
Shekhar Sehgal
Manish Khanolkar
机构：
[1] Waikato Hospital,Diabetes and Endocrinology registrar, Department of Endocrinology and Diabetes
[2] Greenlane Clinical Centre,undefined
来源：
Diabetes Therapy | 2015年 / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：99 / 99
相关论文
共 50 条
  • [21] Switching from insulin to dulaglutide therapy in patients with type 2 diabetes: A real-world data study
    Lee, Jiwoo
    Kim, Hwi Seung
    Jung, Chang Hee
    Park, Joong-Yeol
    Lee, Woo Je
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2021, 37 (08)
  • [22] Type 2 Diabetes: How to succeed in Starting of Insulin Therapy?
    Hofmann-Assmus, Marion
    DIABETES STOFFWECHSEL UND HERZ, 2022, 31 (03): : 192 - 192
  • [23] CHANGES IN BODY COMPOSITION AFTER THREE MONTHS OF INSULIN THERAPY IN TYPE 2 DIABETES - A COHORT RETROSPECTIVE STUDY
    Craciun, A.
    Rusu, A.
    Craciun, C. I.
    Bala, C.
    Roman, G.
    Veresiu, I. A.
    Georgescu, C. E.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2015, 11 (03) : 312 - 318
  • [24] Real-world comparative outcomes study in US patients with type 2 diabetes initiating basal insulin analogues
    Davis, K. L.
    Meyers, J. L.
    Tangirala, M.
    Wei, W.
    DIABETOLOGIA, 2012, 55 : S384 - S384
  • [25] Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage (vol 12, pg 1225, 2019)
    Wilke, T.
    Picker, N.
    Mueller, S.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 : 1397 - 1397
  • [26] Type 1 diabetes: analysis of real-world insulin injection patterns
    Catrina, S.
    Hartvig, N.
    Kaas, A.
    Moller, J.
    Mardby, A. -C.
    Jendle, J.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S378 - S378
  • [27] Real-world effectiveness of early insulin therapy on the incidence of cardiovascular events in newly diagnosed type 2 diabetes
    Luo, Sihui
    Zheng, Xueying
    Bao, Wei
    Nie, Sheng
    Ding, Yu
    Yue, Tong
    Zhou, Yilun
    Hu, Ying
    Li, Hua
    Yang, Qiongqiong
    Wan, Qijun
    Liu, Bicheng
    Xu, Hong
    Li, Guisen
    Xu, Gang
    Chen, Chunbo
    Liu, Huafeng
    Shi, Yongjun
    Zha, Yan
    Kong, Yaozhong
    Su, Guobin
    Tang, Ying
    Gong, Mengchun
    Ji, Linong
    Hou, Fan Fan
    Weng, Jianping
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [28] Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety
    Ponzani, Paola
    Berra, Cesare
    Di Lelio, Alessandra
    Del Sindaco, Paola
    Di Loreto, Chiara
    Reggiani, Francesco
    Lucisano, Giuseppe
    Rossi, Maria Chiara
    DIABETES THERAPY, 2018, 9 (06) : 2209 - 2218
  • [29] Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety
    Paola Ponzani
    Cesare Berra
    Alessandra Di Lelio
    Paola Del Sindaco
    Chiara Di Loreto
    Francesco Reggiani
    Giuseppe Lucisano
    Maria Chiara Rossi
    Diabetes Therapy, 2018, 9 : 2209 - 2218
  • [30] Effectiveness and safety of insulin glargine 300 U/mL in insulin-naive patients with type 2 diabetes after failure of oral therapy in a real-world setting
    Pfohl, Martin
    Jornayvaz, Francois R.
    Fritsche, Andreas
    Pscherer, Stefan
    Anderten, Helmut
    Pegelow, Katrin
    Seufert, Jochen
    DIABETES OBESITY & METABOLISM, 2020, 22 (05): : 759 - 766
12345